New study aims to unlock secrets of dry eye disease

NCT ID NCT07025811

First seen Nov 01, 2025 · Last updated May 14, 2026 · Updated 37 times

Summary

This study looks at how well certain biological markers (biomarkers) work to track dry eye disease and how they change with standard treatments like Vevye® or Xiidra®. About 378 people with moderate to severe dry eye and healthy volunteers will take part. The goal is to better understand the disease and improve future diagnosis and treatment.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for DRY EYE DISEASE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Locations

  • Advancing Vision Research, LLC

    Goodlettsville, Tennessee, 37072, United States

  • Andover Eye Associates

    Andover, Massachusetts, 01810, United States

  • Butchertown Clinical Trials

    Louisville, Kentucky, 40206, United States

  • CORE Inc.

    Shelby, North Carolina, 28150, United States

  • Eye Research Foundation

    Newport Beach, California, 92663, United States

  • Oculus Research

    Garner, North Carolina, 27529, United States

  • Piedmont Eye Center

    Lynchburg, Virginia, 24502-4271, United States

  • Total Eyecare, P.A.

    Memphis, Tennessee, 38119, United States

Conditions

Explore the condition pages connected to this study.